On May 29, 2020, Aleafia Health Inc. (TSX: AH) announced that it had closed its previously announced bought deal offering of units for aggregate gross proceeds of $14,950,000, which included the full exercise of the over-allotment option.
The offering was led by Eight Capital on behalf of a syndicate of underwriters including Canaccord Genuity Corp., BMO Capital Markets, Leede Jones Gable Inc., Raymond James Ltd., Mackie Research Capital Corp., and PI Financial Corp.
Aleafia Health is a leading, vertically integrated health and wellness company offering health and wellness services and products in Canada and in international markets. Aleafia Health owns three significant licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history. The company produces a diverse portfolio of commercially proven, high-margin derivative products including oils, capsules and sprays.
Gowling WLG was counsel to Aleafia Health in this offering with a team led by Jason A. Saltzman and Marek Lorenc and that included Kathleen Ritchie, Joseph McDonald and Ryan Cohen (corporate finance and securities) and Paul Carenza (tax), assisted by student-at-law Adam Sherman.
Originally published 29 May 2020
Read the original article on GowlingWLG.com
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.